145 related articles for article (PubMed ID: 8816593)
41. Terminal transferase expression in the differential diagnosis of acute leukemias. Eastern Cooperative Oncology Group.
Meenan B; Heavey C; Lichtenstein A; Andersen J; Paietta E
Leuk Lymphoma; 1996 Jul; 22(3-4):265-9. PubMed ID: 8819075
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
[TBL] [Abstract][Full Text] [Related]
43. Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
Bernstein SH; Brunetto VL; Davey FR; Wurster-Hill D; Mayer RJ; Stone RM; Schiffer CA; Bloomfield CD
J Clin Oncol; 1996 Sep; 14(9):2486-94. PubMed ID: 8823327
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the Beckman Coulter AcT 5 diff AL hematology analyzer in a hospital setting.
Bhuta UM; Ulstein H
Lab Hematol; 2003; 9(3):167-74. PubMed ID: 14521325
[TBL] [Abstract][Full Text] [Related]
45. Evaluation and use of the white blood cell differential provided by the Coulter STKS in a children's hospital.
Fournier M; Adenis C; Fontaine H; Carnaille B; Goudemand J
Clin Lab Haematol; 1994 Mar; 16(1):33-42. PubMed ID: 8039345
[TBL] [Abstract][Full Text] [Related]
46. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
47. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megakaryoblastic (FAB-M7) leukemias.
da Costa M; Ximenes VF; Brunetti IL; Falcão RP; da Fonseca LM
Hematol J; 2004; 5(6):496-9. PubMed ID: 15570291
[TBL] [Abstract][Full Text] [Related]
48. Performance evaluation of the Sysmex XN-1000 hematology analyzer in assessment of the white blood cell count differential in pediatric specimens.
Becker PH; Fenneteau O; Da Costa L
Int J Lab Hematol; 2016 Feb; 38(1):54-63. PubMed ID: 26407903
[TBL] [Abstract][Full Text] [Related]
49. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
50. Myeloperoxidase detection by three-color flow cytometry and by enzyme cytochemistry in the classification of acute leukemia.
Nguyen PL; Olszak I; Harris NL; Preffer FI
Am J Clin Pathol; 1998 Aug; 110(2):163-9. PubMed ID: 9704614
[TBL] [Abstract][Full Text] [Related]
51. [Modern approach to diagnosis and therapy in childhood leukemias].
Hasanbegović E
Med Arh; 2004; 58(1):59-60. PubMed ID: 15017909
[TBL] [Abstract][Full Text] [Related]
52. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
Martín G; Barragán E; Bolufer P; Chillón C; García-Sanz R; Gómez T; Brunet S; González M; Sanz MA
Haematologica; 2000 Jul; 85(7):699-703. PubMed ID: 10897121
[TBL] [Abstract][Full Text] [Related]
53. Correlation between the cell population in the automated hematology analyzer high-fluorescence region and atypical lymphocyte flags.
Xie H; Wu Y; Cui W
J Clin Lab Anal; 2018 Jun; 32(5):e22374. PubMed ID: 29266369
[TBL] [Abstract][Full Text] [Related]
54. Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome.
Novotny JR; Müller-Beissenhirtz H; Herget-Rosenthal S; Kribben A; Dührsen U
Eur J Haematol; 2005 Jun; 74(6):501-10. PubMed ID: 15876254
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the erythrocyte and platelet morphological analysis given by the hematology analyzer Coulter STKS.
Vinatier I; Lorriaux C; Capiod JC; Faille N; Delobel J
Nouv Rev Fr Hematol (1978); 1992; 34(2):205-10. PubMed ID: 1502029
[TBL] [Abstract][Full Text] [Related]
56. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
57. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
Amin HM; Yang Y; Shen Y; Estey EH; Giles FJ; Pierce SA; Kantarjian HM; O'Brien SM; Jilani I; Albitar M
Leukemia; 2005 Sep; 19(9):1567-72. PubMed ID: 16049515
[TBL] [Abstract][Full Text] [Related]
58. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
Arber DA; Stein AS; Carter NH; Ikle D; Forman SJ; Slovak ML
Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285
[TBL] [Abstract][Full Text] [Related]
59. Acute lymphoblastic leukemia with myeloperoxidase activity.
Wright S; Chucrallah A; Chong YY; Kantarjian H; Keating M; Albitar M
Am J Hematol; 1996 Feb; 51(2):147-51. PubMed ID: 8579056
[TBL] [Abstract][Full Text] [Related]
60. Haematological monitoring of acute lymphoblastic leukemia by automated flow cytochemistry (Bayer/Technicon H*1).
Ialongo P; Lubrano MC; Fenu S; Vignetti M; Mandelli F
Haematologica; 1993; 78(2):89-94. PubMed ID: 8394278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
